天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

上海瀚香生物科技有限公司 公司信息

公司名稱(chēng): 上海瀚香生物科技有限公司
電話: 177-54423994
電子郵件:2853530910@QQ.com
國(guó)籍:中國(guó)
網(wǎng)址: www.biochempartner.com
產(chǎn)品總數(shù):7999
60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80

公司提供產(chǎn)品列表

1-(2-Methoxy-5-methylphenyl)ethanone 1-(2-甲氧基-5-甲基苯基)乙酮 20628-07-3
Motavizumab 莫維珠單抗 677010-34-3
BMS-191011 202821-81-6
NGB2904 189060-98-3
Apolizumab 阿泊珠單抗 267227-08-7
JTE-607 dihydrochloride 188791-09-5
Pax2 inhibitor EG1 693241-54-2
Lenacapavir HIV-1衣殼抑制劑GS-6207 2189684-44-2
NNMTi 42464-96-0
Meplazumab 美珀珠單抗 2413715-21-4
ICCB-19 HCl 1803605-68-6
NSC 2805 4371-34-0
JHN76359 1715076-35-9
Caroverine hydrochloride 卡羅維林鹽酸鹽 55750-05-5
2-(Pyrrolidin-1-yl)acetic acid hydrochloride 2-(吡咯烷-1-基)乙酸鹽酸鹽 6628-74-6
LM11A-31 dihydrochloride 1243259-19-9
(2S,1'R,2'S)-N-(tert-butoxycarbonyl)-2-(1'-hydroxy-2'-Methyl-3'-butenyl)-pyrrolidine 159173-40-7
AAL-993 269390-77-4
CC-885 1010100-07-8
UoS12258 875927-64-3
IT-603 292168-90-2
RG7834 2072057-17-9
5-hydroxy-3,9-dimethyl-7H-benzo[c]fluoren-7-one 5-羥基-3,9-二甲基-7H-苯并[c]芴-7-酮 80826-37-5
iBET-BD1 2451862-42-1
SCO-267 1656261-09-4
MIPS521 1146188-19-3
ARP100 704888-90-4
Foravirumab 福拉韋單抗 944548-38-3
Pascolizumab 帕考珠單抗 331243-22-2
Siplizumab 西利珠單抗 288392-69-8
AZ10606120 dihydrochloride 607378-18-7
Visilizumab 維西珠單抗 219716-33-3
CRT-0066101 956121-30-5
CAROVERINE 卡羅維林 23465-76-1
dupilumab 度匹魯單抗 1190264-60-8
ONC206 1638178-87-6
Giredestrant tartrate 2407529-33-1
Narsoplimab 納索利單抗 2108782-45-0
HPK1-IN-7 2320462-65-3
Pexelizumab 培克珠單抗 219685-93-5
Dup-721 N-[[3-(4-乙?；交?-2-氧代-1,3-惡唑烷-5-基]甲基]乙酰胺 104421-21-8
Bisindolylmaleimide VIII Acetic Acid Salt 138516-31-1
Hydroxyibuprofen 2-羥基布洛芬 51146-55-5
N-(2-Aminoethyl)-2-(2,6-dichlorophenoxy)propanamide 洛非西定雜質(zhì)和衍生物 344443-16-9
ONC-212 1807861-48-8
VAL083 去水衛(wèi)矛醇 23261-20-3
Felvizumab 泛維珠單抗 167747-20-8
CL-82198 307002-71-7
Ethyl 8-amino-4-oxo-4H-chromene-2-carboxylate 8-氨基-4-氧代-4H-1-苯并吡喃-2-羧酸乙酯 103195-35-3
TNKS656 1419949-20-4
JFD01307SC 51070-56-5
CITCO 338404-52-7
Amatuximab 阿麥妥單抗 931402-35-6
((4S,5S)-Cy2-Ubaphox)Ir(COD)]BARF 880262-14-6
Rafivirumab 雷韋單抗 944548-37-2
Zinpyr-1 288574-78-7
Cedelizumab 西利珠單抗 156586-90-2
RVX297 1044871-04-6
SRS16-86 1793052-96-6
LQZ-7I 195822-23-2
sulfopin 2451481-08-4
((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane ((2-氟-6-(甲氧基甲氧基)-8-(4,4,5,5-四甲基-1,3,2-二氧雜硼硼烷-2-基)萘-1-基)乙炔基)三異丙基硅烷 2621932-37-2
Pimethixene 匹美噻噸 314-03-4
2H-Indol-2-one, 1,3-dihydro-3-(4-hydroxyphenyl)-3-[4-(trifluoromethoxy)phenyl]-7-(trifluoromethyl)-, (3S)- 2407860-34-6
CP-31398 Dihydrochloride Hydrate 1217195-61-3
PU-H54 1454619-13-6
Pimethixene maleate 馬來(lái)酸甲哌硫蒽 13187-06-9
PF-05231023 1037589-69-7
CC90010 1706738-98-8
Senaparib 1401682-78-7
LY 2979165 1311385-35-9
Efalizumab 依法珠單抗 214745-43-4
MCP110 521310-51-0
BTTAA 1334179-85-9
HJC0197 1383539-73-8
Labetuzumab 拉貝珠單抗 219649-07-7
Tolebrutinib 1971920-73-6
Indirubin-3'-oxime 667463-82-3
AZD-0284 2101291-07-8
MT802 2231744-29-7
CLK-IN-T3 2109805-56-1
NI-42 1884640-99-6
Dot1L-IN-4 2565705-02-2
Simufilam 1224591-33-6
PTI-125 hydrochloride 2480226-07-9
Lintuzumab 林妥珠單抗 166089-32-3
N-[4-(6-Fluoro-3,4-dihydro-2(1H)-isoquinolinyl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide N-[4-(6-氟-3,4-二氫-2(1H)-異喹啉基)-2,6-二甲基苯基]-3,3-二甲基丁酰胺 1009344-33-5
IWP-4 686772-17-8
(S)-2,2-Dimethyl-cyclopropanecarboxylic acid ethyl ester 西司他丁雜質(zhì)SM2-D 89007-61-4
PIM1-IN-1 1417630-95-5
Spongosine 24723-77-1
(6R)-FR054 35954-65-5
Gevokizumab 吉伏組單抗 1129435-60-4
Galloflavin 棓黃素 568-80-9
HT-61 936622-80-9
Bisindolylmaleimide IV 119139-23-0
GSK840 2361146-30-5
Siltuximab 塞妥昔單抗 541502-14-1
LM11A-31 289475-77-0
JNJ67856633 2230273-76-2
60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2007? ChemicalBook. All rights reserved.